CagriSema: Awaiting a Critical FDA Decision Novo Nordisks CagriSema represents one of the most consequential pending decisions across the GLP-1 drug pipeline in 2026
How GLP-1 Medications Change the Experience GLP-1 medications work by targeting the biological pathways that regulate appetite
The answer from the panelists was a resounding Im not sure
Confirmatory large-scale trials are essential to ascertain the potential efficacy of GLP-1RAs in specifically improving the stroke outcomes
Table 4 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin in Adults with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Sitagliptin, Both as Add-on to Metformin In this 26-week, open-label trial, 665 adult patients with type 2 diabetes mellitus on a background of metformin 1,500 mg per day were randomized to liraglutide injection 1.2 mg once daily, liraglutide injection 1.8 mg once daily or sitagliptin 100 mg once daily, all dosed according to approved labeling
What is the best day of the week to take GLP-1s
)
